Zhang et al. (2019) designed and synthesized a series of (3-hydroxypyridin-4-one)-coumarin hybrids (80) targeting iron ion and monoamine oxidase B (MAO-B) cooperatively for the treatment of AD. The gene discussed is MAOB; the disease is Alzheimer disease.